Creo Medical Group plc (LSE: CREO) is a medical device company developing advanced energy-based surgical systems for minimally invasive procedures. Its CROMA platform powers a suite of tools designed for precision cutting and coagulation in gastrointestinal, urology, and oncology applications. Creo aims to improve patient outcomes and reduce procedure costs through next-generation surgical innovation and global clinical adoption.
最新股票文章

為何麥可·貝瑞(Michael Burry)剛剛清倉所有股票
麥可·貝瑞剛剛拋售了超過7,000萬美元的股票,清空了他的整個投資組合,只保留一支股票,並對這家公司加碼,而其他投資人則紛紛出逃。
18:37, 22 7月 2025